Abbott India share news, announcements and annual reports
NSE: ABBOTINDIABSE: 500488Pharmaceuticals & BiotechnologyMid Cap
Abbott India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1966
Last close ₹25,635.00down ₹510.00 (1.95%)BSE ₹25,593.30
Share price at the NSE close on 30 Oct 2026. Previous close ₹26,145.00.
30 Oct: open ₹26,005.00, high ₹26,455.00, low ₹25,555.00
52-week range of traded prices to 30 Oct 2026
₹24,650.00Low, 23 Oct 2026₹30,655.00High, 25 Nov 2025
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹54,473 Cr183rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.56%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 39.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,62143.4% delivered
Abbott India share news and announcements
558 announcements, routine notices left out, newest first. Page 11 of 12.
Apr 2013
Mar 2013
Feb 2013
20 Feb · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from April 18, 2013 to April 25, 2013 (both days inclusive) for the ....20 Feb · Dividend
Board of Directors of the Company at its meeting held on February 20, 2013, inter alia, have recommended a final dividend for the current ....20 Feb · Results
20 Feb · Board meeting
1. Mr. Laurent Van Lerberghe and Mr. Ramon F. Neira Hoyos resigned as Directors effective February 20, 2013. 2. The Board, at its meeting ....13 Feb · Board meeting
Meeting of the Board of Directors of the Company will be held on February 20, 2013, inter alia, for the following: 1. To consider and approve ....
Jan 2013
10 Jan · Results
Company shall be publishing the Audited Results for the year ended December 31, 2012 within the stipulated period of 60 days.
Nov 2012
Aug 2012
Jun 2012
May 2012
Mar 2012
15 Mar · Management
1. Mr. Vivek Mohan has been offered a global role in the Abbott Group as Senior Director - Global Integrated Health, Established Pharmaceuticals ....7 Mar · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from May 08, 2012 to May 14, 2012 (both days inclusive) for the purpose ....
Feb 2012
28 Feb · Meeting
Board of Directors of the Company at its meeting held on February 28, 2012, inter alia, has recommended a final dividend of Rs. 17.00 per equity ....28 Feb · Results
Nov 2011
1 Nov · Results
Sep 2011
7 Sep · Business
Committee of Directors appointed for purpose of allotment of shares has at its meeting held September 07, 2011 allotted 75,74,062 equity shares ....
Aug 2011
12 Aug · Results
11 Aug · Results
10 Aug · Business
Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd with Abbott India Ltd has been ....
Jul 2011
15 Jul · Business
Hon'ble High Court of Bombay, on July 15, 2011, has sanctioned the Scheme of Amalgamation of Solvay Pharma India Limited, the Transferor Company ....
May 2011
24 May · Updates
On May 17, 2011 Abbott Capital India Limited sold 224000 of the 9428184 shares held by it in Abbott India Limited by way of an on market ....3 May · Meeting
Shareholders at the 67th Annual General Meeting (AGM) of the Company held on April 27, 2011, inter alia, have confirmed the appointment of below ....
Apr 2011
27 Apr · Results
Mar 2011
23 Mar · Outcome of Court convened Meeting
4 Mar · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from April 21, 2011 to April 27, 2011, (both days inclusive) for ....3 Mar · Board meeting
Board of Directors of the Company at its meeting held on February 28, 2011, has appointed following Additional Directors: 1. Mr. Kaiyomarz Marfatia ....
Feb 2011
28 Feb · Dividend
Board of Directors of the Company at its meeting held on February 28, 2011, inter alia, recommended a final dividend of Rs. 17.00 per equity share ....21 Feb · Board meeting
Meeting of the Board of Directors of the Company will be held on February 28, 2011, inter alia, for the following: 1. To consider and approve ....
Jan 2011
10 Jan · Results
Company shall be publishing the Audited Results for the 13 months period ended December 31, 2010 within the stipulated period of 60 days.
Dec 2010
24 Dec · Management
Mr. Zahirali Lavji has resigned as director on the Board with effect from December 31, 2010.21 Dec · Results
Nov 2010
24 Nov · Board meeting
Boards of Directors of Abbott India Ltd. ("Abbott India") and Solvay Pharma India Ltd. ("Solvay Pharma India"), at their meetings held on November ....1 Nov · Board Meeting on Nov 24, 2010
Meeting of the Board of Directors of the Company will be held on November 24, 2010, to consider a proposal for Merger of Solvay Pharma India Ltd. ....
Sep 2010
28 Sep · Results
Jun 2010
29 Jun · Change of Accounting Year of the Company
Board of Directors of the Company at its meeting held on June 29, 2010, inter alia, has decided to change the accounting year of the Company from ....29 Jun · Results